Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Healthcare Sector — March 2026

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume

iBio, Inc. (IBIO)

Brenner Martin — Director
Mar 19, 2026
Purchase
Shares
12,336
Price
$2.02
Total Value
$24.92K
Shares Held After
30,652
% of Holdings
40.2%
Mar 19, 2026
Sale
Shares
6,905
Price
$18.78
Total Value
$129.70K
Shares Held After
339,392
% of Holdings
2.0%
Mar 19, 2026
Sale
Shares
40,232
Price
$9.21
Total Value
$370.54K
Shares Held After
1,650,812
% of Holdings
2.4%
Mar 19, 2026
Purchase
Shares
70,000
Price
$1.40
Total Value
$98.00K
Shares Held After
195,000
% of Holdings
35.9%
Mar 19, 2026
Sale
Shares
40
Price
$532.90
Total Value
$21.32K
Shares Held After
40,513
% of Holdings
0.1%
Mar 19, 2026
Sale
Shares
240
Price
$531.90
Total Value
$127.66K
Shares Held After
40,553
% of Holdings
0.6%
Mar 19, 2026
Sale
Shares
1,431
Price
$531.20
Total Value
$760.15K
Shares Held After
40,793
% of Holdings
3.4%
Mar 19, 2026
Sale
Shares
1,608
Price
$530.20
Total Value
$852.56K
Shares Held After
42,224
% of Holdings
3.7%
Mar 19, 2026
Sale
Shares
1,950
Price
$529.32
Total Value
$1.03M
Shares Held After
43,832
% of Holdings
4.3%
Mar 19, 2026
Sale
Shares
1,241
Price
$528.31
Total Value
$655.63K
Shares Held After
45,782
% of Holdings
2.6%
Mar 19, 2026
Sale
Shares
1,515
Price
$527.30
Total Value
$798.86K
Shares Held After
47,023
% of Holdings
3.1%
Mar 19, 2026
Sale
Shares
876
Price
$526.27
Total Value
$461.01K
Shares Held After
48,538
% of Holdings
1.8%
Mar 19, 2026
Sale
Shares
599
Price
$525.08
Total Value
$314.52K
Shares Held After
49,414
% of Holdings
1.2%

SOPHiA GENETICS SA (SOPH)

Xu Zhenyu — Chief Scientific Officer
Mar 19, 2026
Sale
Shares
608
Price
$4.78
Total Value
$2.91K
Shares Held After
537,116
% of Holdings
0.1%

SOPHiA GENETICS SA (SOPH)

CARDOZA GEORGE — Chief Financial Officer
Mar 19, 2026
Sale
Shares
774
Price
$4.79
Total Value
$3.70K
Shares Held After
184,858
% of Holdings
0.4%

SOPHiA GENETICS SA (SOPH)

Valente Manuela — Chief People Officer
Mar 19, 2026
Sale
Shares
380
Price
$4.79
Total Value
$1.82K
Shares Held After
152,379
% of Holdings
0.2%

SOPHiA GENETICS SA (SOPH)

Menu Philippe — Chief Medical Officer
Mar 19, 2026
Sale
Shares
608
Price
$4.79
Total Value
$2.91K
Shares Held After
173,616
% of Holdings
0.3%

SOPHiA GENETICS SA (SOPH)

Van Well Daan — Chief Legal Officer
Mar 19, 2026
Sale
Shares
684
Price
$4.79
Total Value
$3.27K
Shares Held After
261,238
% of Holdings
0.3%

INSMED Inc (INSM)

Lewis William — Director
Mar 19, 2026
Sale
Shares
4,533
Price
$144.11
Total Value
$653.25K
Shares Held After
301,185
% of Holdings
1.5%

INSMED Inc (INSM)

Lewis William — Director
Mar 19, 2026
Sale
Shares
4,537
Price
$143.42
Total Value
$650.70K
Shares Held After
305,718
% of Holdings
1.5%

INSMED Inc (INSM)

Lewis William — Director
Mar 19, 2026
Sale
Shares
1,629
Price
$142.17
Total Value
$231.59K
Shares Held After
310,255
% of Holdings
0.5%

SOPHiA GENETICS SA (SOPH)

Puylaert Kevin — Chief Sales Officer
Mar 19, 2026
Sale
Shares
33
Price
$4.76
Total Value
$157.08
Shares Held After
92,386
% of Holdings
0.0%
Mar 19, 2026
Sale
Shares
4,486
Price
$4.77
Total Value
$21.41K
Shares Held After
3,302,839
% of Holdings
0.1%

SOPHiA GENETICS SA (SOPH)

Muken Ross — President
Mar 19, 2026
Sale
Shares
1,183
Price
$4.79
Total Value
$5.67K
Shares Held After
271,910
% of Holdings
0.4%

HENRY SCHEIN INC (HSIC)

Popeck Thomas C — CEO, Henry Schein Products
Mar 19, 2026
Sale
Shares
1,355
Price
$72.79
Total Value
$98.63K
Shares Held After
86,182
% of Holdings
1.5%

Serina Therapeutics, Inc. (SER)

Moreadith Randall — Chief Scientific Officer
Mar 19, 2026
Sale
Shares
39,000
Price
$2.50
Total Value
$97.50K
Shares Held After
0
% of Holdings
100.0%
Mar 19, 2026
Purchase
Shares
77,702
Price
$2.64
Total Value
$205.13K
Shares Held After
6,753,761
% of Holdings
1.2%

Neuronetics, Inc. (STIM)

Chernett Jorey — 10% Owner
Mar 19, 2026
Purchase
Shares
450,000
Price
$1.33
Total Value
$598.50K
Shares Held After
8,573,804
% of Holdings
5.2%
Mar 19, 2026
Sale
Shares
124
Price
$53.24
Total Value
$6.60K
Shares Held After
73,320
% of Holdings
0.2%
Mar 19, 2026
Sale
Shares
4,977
Price
$52.79
Total Value
$262.72K
Shares Held After
73,444
% of Holdings
6.3%
Mar 19, 2026
Sale
Shares
1,939
Price
$51.78
Total Value
$100.41K
Shares Held After
78,421
% of Holdings
2.4%

Revolution Medicines, Inc. (RVMD)

Cislini Jeff — General Counsel
Mar 19, 2026
Sale
Shares
1,163
Price
$97.44
Total Value
$113.32K
Shares Held After
58,518
% of Holdings
1.9%
Mar 19, 2026
Sale
Shares
11,964
Price
$67.00
Total Value
$801.59K
Shares Held After
33,421
% of Holdings
26.4%
Mar 19, 2026
Purchase
Shares
780,009
Price
$11.69
Total Value
$9.12M
Shares Held After
7,648,829
% of Holdings
10.2%

Tarsus Pharmaceuticals, Inc. (TARS)

Farrow Jeffrey S — Chief Financial Officer and Chief Strategy Officer
Mar 19, 2026
Sale
Shares
2,186
Price
$67.00
Total Value
$146.46K
Shares Held After
43,316
% of Holdings
4.8%

Tarsus Pharmaceuticals, Inc. (TARS)

Neervannan Seshadri — Chief Operating Officer
Mar 19, 2026
Sale
Shares
4,589
Price
$67.00
Total Value
$307.46K
Shares Held After
85,780
% of Holdings
5.1%

Tarsus Pharmaceuticals, Inc. (TARS)

Lin Elizabeth Yeu — Chief Medical Officer
Mar 19, 2026
Sale
Shares
390
Price
$67.00
Total Value
$26.13K
Shares Held After
23,308
% of Holdings
1.6%

Tarsus Pharmaceuticals, Inc. (TARS)

Whitfield Dianne C. — Chief Human Resources Officer
Mar 19, 2026
Sale
Shares
4,174
Price
$67.00
Total Value
$279.66K
Shares Held After
35,028
% of Holdings
10.6%

Tarsus Pharmaceuticals, Inc. (TARS)

Mottiwala Aziz — Chief Commercial Officer
Mar 19, 2026
Sale
Shares
4,440
Price
$67.00
Total Value
$297.48K
Shares Held After
61,480
% of Holdings
6.7%

Tarsus Pharmaceuticals, Inc. (TARS)

Wahl Bryan — General Counsel
Mar 19, 2026
Sale
Shares
4,231
Price
$67.00
Total Value
$283.48K
Shares Held After
63,959
% of Holdings
6.2%

Alignment Healthcare, Inc. (ALHC)

Wagner Andreas P. — Chief Human Resources Officer
Mar 19, 2026
Sale
Shares
11,602
Price
$18.22
Total Value
$211.40K
Shares Held After
148,628
% of Holdings
7.2%

PROCEPT BioRobotics Corp (PRCT)

Nouri Alaleh — EVP, CLO, CORP. SEC.
Mar 19, 2026
Sale
Shares
2,332
Price
$26.15
Total Value
$60.97K
Shares Held After
105,354
% of Holdings
2.2%

PROCEPT BioRobotics Corp (PRCT)

Nouri Alaleh — EVP, CLO, CORP. SEC.
Mar 19, 2026
Sale
Shares
3,031
Price
$25.82
Total Value
$78.26K
Shares Held After
107,686
% of Holdings
2.7%

Stoke Therapeutics, Inc. (STOK)

Ticho Barry — CHIEF MEDICAL OFFICER
Mar 19, 2026
Sale
Shares
1,461
Price
$29.99
Total Value
$43.82K
Shares Held After
40,702
% of Holdings
3.5%

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP & GENERAL COUNSEL
Mar 19, 2026
Sale
Shares
80
Price
$533.41
Total Value
$42.67K
Shares Held After
45,172
% of Holdings
0.2%

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP & GENERAL COUNSEL
Mar 19, 2026
Sale
Shares
650
Price
$532.50
Total Value
$346.12K
Shares Held After
45,252
% of Holdings
1.4%

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP & GENERAL COUNSEL
Mar 19, 2026
Sale
Shares
794
Price
$531.62
Total Value
$422.11K
Shares Held After
45,902
% of Holdings
1.7%

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP & GENERAL COUNSEL
Mar 19, 2026
Sale
Shares
1,776
Price
$530.63
Total Value
$942.41K
Shares Held After
46,696
% of Holdings
3.7%

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP & GENERAL COUNSEL
Mar 19, 2026
Sale
Shares
2,808
Price
$529.82
Total Value
$1.49M
Shares Held After
48,472
% of Holdings
5.5%

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP & GENERAL COUNSEL
Mar 19, 2026
Sale
Shares
1,439
Price
$528.41
Total Value
$760.38K
Shares Held After
51,280
% of Holdings
2.7%
Version: v26.3.29